Faculty Rank

Associate Professor

Undergraduate Education

Federal University of Paraná, Curitiba, Paraná - Brazil, B.S. (Pharmacy/Biochemistry)

Graduate Education

East Carolina University, Greenville, NC, M.S. (Biology)

East Carolina University, Greenville, NC  Ph.D. (Microbiology/Immunology)

Boards

American Board of Histocompatibility and Immunogenetics

Clinical Interests

Histocompatibility Testing and Transplantation

Research Interests

Transplantation Immunobiology, Post-Transplant Follow Up, Donor-Specific Hyporesponsiveness, Cytokine Gene Polymorphisms, Xenotransplantation

Selected Publications

1.  Rebellato LM, Verbanac KM, and Haisch CE. The current status of xenotransplantation. Current Surgery. 2005;62(5):481-488.

2.  Verbanac KM, Rebellato LM, Haisch CE. The Immune System and the Immunocompromised Patient. In Thomas Miller, ed. 4th edition. Physiological Basis of Modern Surgical Care. St Louis, MO; Quality Medical Publishing; 2004.

3.  Arnold AN and Rebellato, LM.  Cadaveric renal transplants without delayed graft function have outcomes equivalent to living donor renal transplants: a six-year experience from two transplant centers. American Journal of Transplantation. 2003;3(Suppl 5):Abstract #1388.

4.  Hewan-Lowe K, Rebellato L, Finley J, Nzerue C. Locations of Post Transplant Neoplasia Influences Diagnosis and Graft Outcome. J Am Soc Nephrol. 2003;14:924A.

5.  Rebellato LM, Briley KP, Hewan-Lowe K. Serum anti-HLA anitbody and C4d staining of allograft biopsies are adequate tools for the diagnosis of humoral rejection. Human Immunology. 2003;64(Suppl 1):S62.

6.  Arnold AN and Rebellato, LM. The impact of HLA and CREG matching on the five-year results with living unrelated donor renal transplantation. Human Immunology. 2002;63(Suppl 1):S29.

7.  Manning CH, Rebellato-de Vente L, and Briley K. Cytoline gene polymorphisms in Caucasian and African-American renal allograft recipients. Human Immunology. 2002;63(Suppl 1):S49.

8.  Reinsmoen NL, Manning C, Rebellato LM, Schmitz J, and Thacker  MS. Limiting HLA-B, DR mismatches is especially beneficial to sensitize racial minority patients. American Journal of Transplantation. 2002;2(Suppl 3):Abstract #39.

9.  Rebellato LM, Arnold AN, Bozik KM, Haisch CE.  HLA matching and the United Network for organ sharing (UNOS) allocation system: impact of HLA matching on African American recipients of cadaveric kidney transplants.  Transplantation 74(11): 1634-1636, December, 2002.

10. Rebellato LM, Dobbs, L.J. Haploidentical Transplantation: importance of histocompatibility testing and chimerism studies in allogeneic bone marrow/stem cell transplantation. Journal of Infusion Nursing. 24(5):311-318, September/October, 2001.

11. Rebellato LM, Manning C, Verbanac KM, Pittman HP, Bozki K, Haisch CE, and Heise E. Post-Transplant follow up study for anti-donor HLA antibody in renal recipients. Human Immunology.  2001;62(Suppl 1):Abstract #164.

Selected Presentations

1.  Hewan-Lowe K, Rebellato L, Finley J, Nzerue C. Location of Post Transplant Neoplasia Influences Diagnosis and Graft Outcome. Poster presented at the American Society of Nephrology; Nov 12-17, 2003; San Diego, CA.

2.  Rebellato LM, Briley KP, Hewan-Lowe K. Serum anti-HLA antibody and C4d staining of allograft biopsies are adequate tools for the diagnosis of humoral rejection. Poster presented at the 29th Annual Meeting of American Society for Histocompatibility and Immunogenetics; Oct 30, 2003; Miami, FL.

3.  Arnold AN, Rebellato LM. Cadaveric renal transplants without delayed graft function have outcomes equivalent to living donor renal transplants: a six-year experience from two transplant centers. Poster presented at the American Transplant Congress 2003; Jun 3, 2003; Washington, DC.

4.  Sutton AT, Rebellato-de Vente L, and Hewan-Lowe KO.  Small viral particles lead to major disease in renal transplant. Presented at the Ultrastructure Meeting; Aug 2002; Aspen, Colorado.